80 related articles for article (PubMed ID: 24977785)
1. Toward anticancer immunotherapeutics: well-defined polymer-antibody conjugates for selective dendritic cell targeting.
Tappertzhofen K; Bednarczyk M; Koynov K; Bros M; Grabbe S; Zentel R
Macromol Biosci; 2014 Oct; 14(10):1444-57. PubMed ID: 24977785
[TBL] [Abstract][Full Text] [Related]
2. Selective uptake of cylindrical poly(2-oxazoline) brush-antiDEC205 antibody-OVA antigen conjugates into DEC-positive dendritic cells and subsequent T-cell activation.
Bühler J; Gietzen S; Reuter A; Kappel C; Fischer K; Decker S; Schäffel D; Koynov K; Bros M; Tubbe I; Grabbe S; Schmidt M
Chemistry; 2014 Sep; 20(39):12405-10. PubMed ID: 25111768
[TBL] [Abstract][Full Text] [Related]
3. Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.
Stylianou E; Pepponi I; van Dolleweerd CJ; Paul MJ; Ma JK; Reljic R
Vaccine; 2011 Mar; 29(12):2279-86. PubMed ID: 21272603
[TBL] [Abstract][Full Text] [Related]
4. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
5. PE-Cy5.5 conjugates bind to the cells expressing mouse DEC205/CD205.
Park CG; Rodriguez A; Steinman RM
J Immunol Methods; 2012 Oct; 384(1-2):184-90. PubMed ID: 22841832
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting.
Li L; Yang Q; Zhou Z; Zhong J; Huang Y
Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960
[TBL] [Abstract][Full Text] [Related]
7. Targeting cells of the immune system: mannosylated HPMA-LMA block-copolymer micelles for targeting of dendritic cells.
Mohr N; Kappel C; Kramer S; Bros M; Grabbe S; Zentel R
Nanomedicine (Lond); 2016 Oct; 11(20):2679-2697. PubMed ID: 27628185
[TBL] [Abstract][Full Text] [Related]
8. The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.
Cruz LJ; Tacken PJ; Fokkink R; Figdor CG
Biomaterials; 2011 Oct; 32(28):6791-803. PubMed ID: 21724247
[TBL] [Abstract][Full Text] [Related]
9. Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response.
Tenbusch M; Nchinda G; Storcksdieck genannt Bonsmann M; Temchura V; Überla K
Int Immunol; 2013 Apr; 25(4):247-58. PubMed ID: 23184617
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy.
Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K
J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933
[TBL] [Abstract][Full Text] [Related]
11. Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice.
Mahnke K; Qian Y; Fondel S; Brueck J; Becker C; Enk AH
Cancer Res; 2005 Aug; 65(15):7007-12. PubMed ID: 16061687
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants.
Sartorius R; Bettua C; D'Apice L; Caivano A; Trovato M; Russo D; Zanoni I; Granucci F; Mascolo D; Barba P; Del Pozzo G; De Berardinis P
Eur J Immunol; 2011 Sep; 41(9):2573-84. PubMed ID: 21688262
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein impairs human CD14+ monocyte-derived dendritic cell differentiation, maturation and function.
Zhang R; Becnel L; Li M; Chen C; Yao Q
Eur J Immunol; 2006 Nov; 36(11):2993-3006. PubMed ID: 17051617
[TBL] [Abstract][Full Text] [Related]
14. Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy.
Etrych T; Mrkvan T; Ríhová B; Ulbrich K
J Control Release; 2007 Sep; 122(1):31-8. PubMed ID: 17631976
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.
Macho-Fernandez E; Cruz LJ; Ghinnagow R; Fontaine J; Bialecki E; Frisch B; Trottein F; Faveeuw C
J Immunol; 2014 Jul; 193(2):961-9. PubMed ID: 24913977
[TBL] [Abstract][Full Text] [Related]
16. Comparison between linear and star-like HPMA conjugated pirarubicin (THP) in pharmacokinetics and antitumor activity in tumor bearing mice.
Nakamura H; Koziolová E; Etrych T; Chytil P; Fang J; Ulbrich K; Maeda H
Eur J Pharm Biopharm; 2015 Feb; 90():90-6. PubMed ID: 25460144
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of Innate and Adaptive Immunity by Using Filamentous Bacteriophage fd Targeted to DEC-205.
D'Apice L; Costa V; Sartorius R; Trovato M; Aprile M; De Berardinis P
J Immunol Res; 2015; 2015():585078. PubMed ID: 26380324
[TBL] [Abstract][Full Text] [Related]
18. A novel CD4-CD8alpha+CD205+CD11b- murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis.
Ruiz S; Beauvillain C; Mévélec MN; Roingeard P; Breton P; Bout D; Dimier-Poisson I
Cell Microbiol; 2005 Nov; 7(11):1659-71. PubMed ID: 16207252
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro evaluation of defined HPMA folate conjugates: influence of aggregation on folate receptor (FR) mediated cellular uptake.
Barz M; Canal F; Koynov K; Zentel R; Vicent MJ
Biomacromolecules; 2010 Sep; 11(9):2274-82. PubMed ID: 20687544
[TBL] [Abstract][Full Text] [Related]
20. Designing polymer conjugates as lysosomotropic nanomedicines.
Duncan R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
